Cargando…

Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168159/
https://www.ncbi.nlm.nih.gov/pubmed/30278084
http://dx.doi.org/10.1371/journal.pone.0205300
_version_ 1783360321409253376
collection PubMed
description
format Online
Article
Text
id pubmed-6168159
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61681592018-10-19 Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer PLoS One Retraction Public Library of Science 2018-10-02 /pmc/articles/PMC6168159/ /pubmed/30278084 http://dx.doi.org/10.1371/journal.pone.0205300 Text en © 2018 The PLOS ONE Editors http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Retraction
Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
title Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
title_full Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
title_fullStr Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
title_full_unstemmed Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
title_short Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
title_sort retraction: anti-tumor activity of a novel compound-cdf is mediated by regulating mir-21, mir-200, and pten in pancreatic cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168159/
https://www.ncbi.nlm.nih.gov/pubmed/30278084
http://dx.doi.org/10.1371/journal.pone.0205300
work_keys_str_mv AT retractionantitumoractivityofanovelcompoundcdfismediatedbyregulatingmir21mir200andpteninpancreaticcancer